History

Launched HeartMedi+ (for clinical use)

Signed MOU with Ewha Womans University College of Medicine

Selected for Bio Tech Development by MOTIE (6.3B KRW)

Expanded and relocated headquarters

Selected as '2024 Emerging AI+X Top 100' by the Intelligent Information Industry Association

Inno-Biz certification

Secured additional investment of 11 billion KRW

Signed MOU with Daesung Industrial Co., Ltd.

Notified as an innovative medical technology by the Ministry of Health and Welfare (HeartMedi+)

Obtained MFDS Class 3 medical device approval (HeartMedi+)

Designated as an innovative medical device (HeartMedi+)

Signed MOU with Myongji Hospital

Selected as '2023 Emerging AI+X Top 100' by the Intelligent Information Industry Association

FDA 510(k) certification (AutoSeg-H)

Received approval for clinical trial plan from MFDS (HeartMedi+)

Secured additional investment of 1.5 billion KRW

Selected for the Excellent Patent Award in Korea

Launched HeartMedi (research version)

Certified for Intellectual Property Management by the Korean Intellectual Property Office

Selected as a K-Unicorn Rising Star

Obtained MFDS certification as a Class 2 medical device (AutoSeg-H)

Launched AutoSeg (research version)

Established AI Medic Inc. in the U.S.

Secured additional investment of 2 billion KRW

Selected for the SME Administration's Strategic Startup Project (Commercialization of AutoSeg)

Changed company name to 'AI Medic Co., Ltd.'

Secured additional investment of 7 billion KRW

Selected for the POST-TIPS program by the Ministry of SMEs and Startups (5 billion KRW)

Certified with euGMP (ISO13485:2016)

Expanded and relocated headquarters and corporate R&D center to Samseong-dong, Seoul

Received amended approval for clinical trial plan from MFDS

Secured additional investment of 3 billion KRW

Selected for Startup Growth by Korea SMEs Agency (4B KRW)

Received approval for clinical trial plan from MFDS (HeartMedi)

Selected for SME R&D Support Program (AutoSeg Development)

Designated as a military service designated company

Selected for MOHW's Clinical Trial Support Program (12B KRW)

Relocated corporate R&D center to TIPS Town, Yeoksam-dong, Seoul

Certified as a venture company

Secured 5 billion KRW investment and selected for TIPS program

Established a corporate R&D center

Obtained medical device manufacturing license

Obtained medical device manufacturing approval (HeartMedi)

Recognized for GMP (Good Manufacturing Practice)

Signed MOU with Yangsan Pusan National University Hospital

Company name changed to 'Silicon Sapiens Co., Ltd.'

Joined MSIP's New Industry Project (CT-FFR Commercialization)

Company established (Initial company name: Vask System Co., Ltd.)